|
N-[(2R)-2-(Hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan Methylamide
A potent, cell-permeable, broad-spectrum hydroxamic acid inhibitor of matrix metalloproteinases (MMPs); (Ki = 400 pM for MMP-1; Ki = 500 pM for MMP-2; Ki = 27 nM for MMP-3; Ki = 100 pM for MMP-8;
and Ki = 200 pM for MMP-9). Prevents the release of TNF-a in vivo and in vitro and abrogates endotoxin-induced lethality in mice.
Chemical Formula: C20H28N4O4
Molecular Weight: 388.4706
OTAVAchemicals Catalogue Number: 7070707140
CAS Registry Number: 142880-36-2
Purity: 97% (HPLC)
Ref.: Metalloprotease Inhibitors GM6001 and TAPI-0 Inhibit the Obligate Intracellular Human Pathogen Chlamydia trachomatis by Targeting Peptide Deformylase of the Bacterium*Amit Balakrishnan, Bhairavi Pate , Stephan A. Sieber at all. THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 281, NO. 24, pp. 16691–16699.
Abstract: To further assess the cytoprotective effect of ilomastat, primary cardiomyocytes isolated from neonatal rats were subjected to 240min simulated ischemia followed by 120min simulated reperfusion in the presence of ilomastat (5nM-5µM). Ilomastat at 500nM and 5µM significantly increased cell viability when compared to vehicle treated group. To assess the in situ MMP-2 inhibitory effect of ilomastat, in separate experiments in situ zymography was performed in cardiomyocytes. The cytoprotective concentration of ilomastat (500nM) showed a moderate (approximately 25%) inhibition of intracellular MMP-2 in ischemic/reperfused cardiomyocytes. In these cells, MMP-2 immunostaining showed a 90% colocalization with the in situ gelatinolytic activity.
https://doi.org/10.1074/jbc.M513648200
Price info:
|
1 MG |
79 EUR |
|
5 MG |
129 EUR |
|
10 MG |
199 EUR |
|
300uL of 10mM solution |
104 EUR
|
|
HOME
Overview
